Clinical Trial Update: Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and tolerability of single ascending oral doses of PBF-999 in healthy young male volunteers; Huntington's disease is listed as th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• PBF-999

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Huntington's Disease | Phase 1 | Status: COMPLETED